Next-Generation HIV Pre-Exposure Prophylaxis Preferences Among Men Who Have Sex with Men Taking Daily Oral Pre-Exposure Prophylaxis.
Administration, Oral
Adolescent
Adult
Black or African American
/ statistics & numerical data
Anti-HIV Agents
/ administration & dosage
Cross-Sectional Studies
HIV Infections
/ prevention & control
Health Services Accessibility
Homosexuality, Male
/ psychology
Humans
Male
Medication Adherence
Patient Acceptance of Health Care
/ statistics & numerical data
Patient Preference
/ psychology
Pre-Exposure Prophylaxis
/ methods
Sexual Behavior
/ statistics & numerical data
HIV prevention
men who have sex with men
next-generation biomedical interventions
pre-exposure prophylaxis
Journal
AIDS patient care and STDs
ISSN: 1557-7449
Titre abrégé: AIDS Patient Care STDS
Pays: United States
ID NLM: 9607225
Informations de publication
Date de publication:
11 2019
11 2019
Historique:
pubmed:
12
10
2019
medline:
1
4
2020
entrez:
12
10
2019
Statut:
ppublish
Résumé
Next-generation forms of HIV pre-exposure prophylaxis (PrEP) currently in development, including long-acting injectables (LAIs), rectal microbicides (RMs), antibody infusions (AIs), and subdermal implants (SIs), may address barriers to daily oral PrEP uptake and adherence. The purpose of this study was to evaluate barriers to oral PrEP, preferences for next-generation PrEP modalities, sociodemographic characteristics and sexual behaviors associated with preferences, and reasons for wanting or not wanting each formulation among a sample of men who have sex with men (MSM). We administered a cross-sectional survey to a diverse sample of MSM currently taking oral PrEP (
Identifiants
pubmed: 31603712
doi: 10.1089/apc.2019.0093
pmc: PMC6839421
doi:
Substances chimiques
Anti-HIV Agents
0
Types de publication
Journal Article
Research Support, N.I.H., Extramural
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
482-491Subventions
Organisme : NIAID NIH HHS
ID : P30 AI042853
Pays : United States
Références
J Acquir Immune Defic Syndr. 2016 Dec 15;73(5):547-555
pubmed: 27454250
AIDS Care. 2008 Jan;20(1):106-15
pubmed: 18278621
MMWR Morb Mortal Wkly Rep. 2015 Nov 27;64(46):1291-5
pubmed: 26606148
Sex Health. 2014 Jul;11(3):244-51
pubmed: 25001553
HIV AIDS (Auckl). 2015 Oct 13;7:241-9
pubmed: 26508889
J Int AIDS Soc. 2016 Jun 13;19(1):20903
pubmed: 27302837
Infection. 2016 Apr;44(2):151-8
pubmed: 26471511
Soc Sci Med. 2008 Aug;67(3):478-86
pubmed: 18508171
LGBT Health. 2018 Aug/Sep;5(6):341-349
pubmed: 30118399
Am J Public Health. 2003 Jun;93(6):926-32
pubmed: 12773357
AIDS Patient Care STDS. 2017 Feb;31(2):60-77
pubmed: 28170304
AIDS Behav. 2014 Sep;18(9):1722-5
pubmed: 25017425
Sex Transm Dis. 2016 Nov;43(11):717-723
pubmed: 27893604
Drug Deliv Transl Res. 2017 Dec;7(6):805-816
pubmed: 28612340
Soc Sci Med. 2017 Jan;172:115-123
pubmed: 27866750
AIDS. 2017 Mar 13;31(5):731-734
pubmed: 28060019
Int J STD AIDS. 2018 Mar;29(4):375-381
pubmed: 28853676
Lancet. 2016 Jan 2;387(10013):53-60
pubmed: 26364263
PLoS One. 2017 Sep 27;12(9):e0184014
pubmed: 28953905
AIDS Patient Care STDS. 2017 Nov;31(11):470-478
pubmed: 29087744
AIDS Patient Care STDS. 2017 Dec;31(12):504-516
pubmed: 29211514
AIDS Behav. 2019 Oct;23(10):2706-2709
pubmed: 30874995
J Acquir Immune Defic Syndr. 2017 Nov 1;76(3):250-258
pubmed: 28708811
PLoS One. 2017 Feb 21;12(2):e0172354
pubmed: 28222118
PLoS One. 2018 Jul 19;13(7):e0200296
pubmed: 30024903
PLoS One. 2017 Aug 21;12(8):e0183521
pubmed: 28827821
AIDS Care. 2018 Jan;30(1):9-17
pubmed: 28791876
AIDS Patient Care STDS. 2016 Jun;30(6):282-90
pubmed: 27220036
Sex Transm Infect. 2008 Nov;84(6):483-7
pubmed: 19028952
PLoS Med. 2014 Mar 04;11(3):e1001613
pubmed: 24595035
AIDS Behav. 2018 Apr;22(4):1184-1189
pubmed: 28913659
J Gen Intern Med. 2007 Sep;22(9):1286-91
pubmed: 17597350
AIDS Behav. 2017 May;21(5):1336-1349
pubmed: 27770215
AIDS Behav. 2016 Jul;20(7):1390-9
pubmed: 27000145
Ann Epidemiol. 2017 Apr;27(4):238-243
pubmed: 28325538